# SLC41A3

## Overview
SLC41A3 is a gene that encodes the protein solute carrier family 41 member 3, which is a transmembrane protein localized in the inner mitochondrial membrane. This protein functions as a magnesium (Mg2+) efflux system, crucial for maintaining cellular magnesium homeostasis. Unlike other magnesium transporters, SLC41A3 operates through a sodium (Na+)-dependent mechanism and is not inhibited by imipramine, indicating a unique mode of action. The protein's activity is essential for cellular bioenergetics, as magnesium is vital for ATP stabilization and enzyme function. Dysfunction in SLC41A3 has been linked to various clinical conditions, including hypomagnesemia and potentially degenerative diseases, highlighting its significance in both cellular and organismal health (Mastrototaro2016Solute).

## Function
SLC41A3 encodes a mitochondrial protein that functions as a magnesium (Mg2+) efflux system, playing a crucial role in maintaining magnesium homeostasis within cells. This protein is localized in the inner mitochondrial membrane and facilitates the extrusion of Mg2+ from mitochondria, a process that is dependent on the presence of sodium (Na+) in the external environment (Mastrototaro2016Solute). The Mg2+ efflux system is temperature-sensitive, with reduced activity at lower temperatures, indicating its dynamic nature in response to environmental conditions (Mastrototaro2016Solute).

SLC41A3 is distinct from other Mg2+ transporters, such as SLC41A1, as it is not inhibited by imipramine, a known Na+/Mg2+ exchange inhibitor, suggesting a unique mechanism of action (Mastrototaro2016Solute). The protein's activity is crucial for cellular bioenergetics, as Mg2+ is essential for stabilizing ATP and serving as a cofactor for various enzymes involved in energy production (Mastrototaro2016Solute). In healthy cells, SLC41A3 contributes to the regulation of intracellular Mg2+ levels, impacting cellular energy metabolism and potentially influencing organismal health, particularly in the context of age-related diseases and magnesium deficiency (Mastrototaro2016Solute).

## Clinical Significance
Mutations or alterations in the expression of the SLC41A3 gene have been implicated in several clinical conditions, primarily related to magnesium homeostasis. SLC41A3 is crucial for maintaining magnesium balance, and its dysfunction can lead to hypomagnesemia, characterized by low serum magnesium levels. This condition can result in symptoms such as cardiac arrhythmias, muscle cramps, and fatigue (de2016Identification).

In Slc41a3 knockout mice, the absence of this gene leads to hypomagnesemia and normomagnesiuria, suggesting a potential renal magnesium leak. This phenotype is similar to patients with renal magnesium wasting, where there is low serum magnesium but normal urinary excretion (de2016Identification). Some Slc41a3 knockout mice also develop hydronephrosis, a condition involving kidney swelling due to fluid accumulation, although the exact mechanism remains unclear (de2016Identification).

Additionally, SLC41A3 is involved in mitochondrial magnesium efflux, and its dysfunction may be linked to degenerative diseases such as Alzheimer's and Parkinson's, as well as metabolic disorders like type 2 diabetes and schizophrenia, which are often associated with magnesium deficiency (Mastrototaro2016Solute). Further research is needed to fully understand the clinical implications of SLC41A3 mutations and their potential role in these diseases.


## References


[1. (de2016Identification) Jeroen H.F. de Baaij, Francisco J. Arjona, Michiel van den Brand, Marla Lavrijsen, Anke L.L. Lameris, René J.M. Bindels, and Joost G.J. Hoenderop. Identification of slc41a3 as a novel player in magnesium homeostasis. Scientific Reports, June 2016. URL: http://dx.doi.org/10.1038/srep28565, doi:10.1038/srep28565. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep28565)

[2. (Mastrototaro2016Solute) Lucia Mastrototaro, Alina Smorodchenko, Jörg R. Aschenbach, Martin Kolisek, and Gerhard Sponder. Solute carrier 41a3 encodes for a mitochondrial mg2+ efflux system. Scientific Reports, June 2016. URL: http://dx.doi.org/10.1038/srep27999, doi:10.1038/srep27999. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep27999)